<DOC>
	<DOCNO>NCT00506194</DOCNO>
	<brief_summary>We design prospective , randomize control study compare benefit insulin therapy OADs correction glucose toxicity short period intensive insulin therapy .</brief_summary>
	<brief_title>Short-Term Intensive Insulin Therapy Induction Long-term Glycemic Control</brief_title>
	<detailed_description>OBJECTIVE—Type 2 diabetes associate defect insulin secretion insulin action . Hyperglycemia may aggravate defect , feature know glucose toxicity . Previous study show acute correction hyperglycemia subject long-standing type 2 diabetes give short-term improvement glycemic control discontinuation insulin . The current study attempt identify characteristic patient newly diagnose type 2 diabetes ( fast glucose &gt; 300mg/dL ) would long-term benefit , term glycemic control , brief course insulin therapy . RESEARCH DESIGN AND METHODS—Newly diagnose type 2 diabetic patient severe hyperglycemia ( fast blood glucose &gt; 300 mg/dL random blood glucose &gt; 400 mg/dL ) hospitalize treated intensive insulin injection 10 14 day . Oral glucose tolerance perform one week intensive insulin treatment . After discharge , patient randomize receive insulin injection oral anti-diabetic drug management . Patients follow clinic adjust medication accord blood glucose level . Oral glucose tolerance test repeat 6 month later , whereas insulin sensitivity beta-cell function evaluate . EXPECTED RESULTS—We respect short-term intensive insulin therapy induce lone-term glycemic control newly diagnose type 2 diabetes severe hyperglycemia .</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Isophane Insulin , Human</mesh_term>
	<mesh_term>Gliclazide</mesh_term>
	<criteria>1 . Newly diagnose type 2 diabetic patient . 2 . Hospitalization due hyperglycemia hyperosmolality syndrome . 3 . Those age 30 80 year old inject insulin . 1 . Pregnant woman . 2 . Impaired liver function ( ALT &gt; 120 U/L ) 3 . Impaired renal function ( Serum creatinine &gt; 3.0 mg/dL ) 4 . Recently suffer MI CVA . 5 . Patients acute intercurrent illness . 6 . 2hour Cpeptide level &lt; 1.8 ng/mL .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>type 2 diabetes</keyword>
	<keyword>oral glucose tolerance test</keyword>
	<keyword>insulin</keyword>
	<keyword>oral anti-diabetic drug</keyword>
	<keyword>ß-cell function</keyword>
</DOC>